This 5-week study will examine the effects of naltrexone on alcohol craving, drinking rates,
and reaction to drinking-related triggers, or cues, in participants' everyday environment and
in laboratory sessions. Participants will monitor and record their daily desires to drink,
environmental circumstances in which urges occur, and drinking behavior using a palm top
computer. Participants will receive naltrexone or a placebo. One week after receiving
medication, all participants will be asked to respond to alcohol-related cues that may or may
not arouse the desire to drink.
Phase:
Phase 4
Details
Lead Sponsor:
National Institute on Alcohol Abuse and Alcoholism (NIAAA)